Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15822 articles
Polymorphisms in the XPC gene affect urinary bladder cancer risk: a case-control study, meta-analyses and trial sequential analyses.
XPC Ala499Val substitution increases urinary bladder cancer risk.
»
01/13/16
ASC-J9(®) suppresses castration resistant prostate cancer progression via degrading the enzalutamide-induced androgen receptor mutant AR-F876L.
Suppressing AR-F876L may then abrogate AR-F876L mediated CRPC cell proliferation.
»
02/25/16
Curcumin: A new candidate for melanoma therapy?
Curcumin can blunt epithelial-to-mesenchymal transition and affect many targets that are involved in melanoma initiation.
»
01/09/16
Phase II Trial of Erlotinib in Elderly Patients with Previously Treated Non-small Cell Lung Cancer: Results of the Lung Oncology Group in Kyushu (LOGiK-0802).
Median progression-free survival period was 5.0 months (95%CI=2.3-7.6 months).
»
03/09/16
Prognostic and diagnostic potential of miR-146a in oesophageal squamous cell carcinoma.
MicroRNA-146a expression level was significantly decreased in ESCC tissue compared with paracancerous tissue (P<0.001).
»
09/26/15
Rifaximin, a non-absorbable antibiotic, inhibits the release of pro-angiogenic mediators in colon cancer cells through a pregnane X receptor-dependent pathway.
Treatment downregulated VEGF secretion, NO release, VEGFR-2 expression, MMP-2 and MMP-9 expression.
»
02/22/16
Impact of IDH1 mutation status on outcome in clinical trials for recurrent glioblastoma.
IDH1 mutated glioblastoma (GB) has a better prognosis than IDH1 wildtype GB.
»
09/16/15
Spontaneous regression of CIN2 in women aged 18-24 years: a retrospective study of a state-wide population in Western Australia.
CIN2 has a high rate of spontaneous regression in young women.
»
07/17/15
Detection of TP53/PIK3CA Mutations in Cell-Free Plasma DNA From Metastatic Breast Cancer Patients Using Next Generation Sequencing.
Mutations in ctDNA can be detected with next generation sequencing in MBC patients.
»
12/25/15
LncRNA Up-regulated in Nonmuscle Invasive Bladder Cancer Facilitates Tumor Growth and Acts as a Negative Prognostic Factor of Recurrence.
lncRNA-UNMIBC played a key role in G0/G1 arrest.
»
05/20/16
< Prev
Next >